Jones Financial Companies
TNXP icon

Jones Financial Companies’s Tonix Pharmaceuticals TNXP Stock Holding History

Jones Financial Companies’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$489 Buy
37
+2
+6% +$26 ﹤0.01% 4757
2026
Q1 		$451 Buy
+35
New +$539 ﹤0.01% 4507

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Jones Financial Companies's TNXP Position: Q2 2026 in Review

Jones Financial Companies increased its Tonix Pharmaceuticals (TNXP) stake by 5.7% in Q2 2026, buying an estimated $26 and bringing the position to 37 shares worth $489. The position accounts for ﹤0.01% of the portfolio, ranked #4757.

Jones Financial Companies first reported a position in TNXP in Q1 2026 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Jones Financial Companies held 37 shares of Tonix Pharmaceuticals worth $489 as of Q2 2026.
  • Jones Financial Companies bought 2 Tonix Pharmaceuticals shares in Q2 2026, an estimated $26.
  • Tonix Pharmaceuticals made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #4757 holding.
  • Jones Financial Companies first reported a position in Tonix Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.